(Q44765635)

English

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

scientific article published in March 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

budesonide/formoterol

1 reference

based on heuristic

inferred from title

2

object named as

Dirkje Postma

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

Roland A Riemersma

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

Thys van der Molen

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

Dirkje Postma

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

publication date

1 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Primary care respiratory journal : journal of the General Practice Airways Group

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

21

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

50-56

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Scientific rationale for using a single inhaler for asthma control

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Development and validation of a questionnaire to measure asthma control.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Severe exacerbations predict excess lung function decline in asthma.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Airways responsiveness and development and remission of chronic respiratory symptoms in adults.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Clinical relevance of airway remodelling in airway diseases

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: a cross-sectional analysis.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00090

21 January 2018

Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring asthma control in group studies: do we need airway calibre and rescue β2-agonist use?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of the satisfaction with inhaled asthma treatment questionnaire

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage and time effects of inhaled budesonide on bronchial hyperreactivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the Eur

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22015542

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4104/PCRJ.2011.00090

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6548307&resulttype=core&format=json

14 May 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44765635&oldid=2206901320"